Tasos Konidaris

Insider Reports History

Entity
Individual
Location
103 Jfk Parkway, Short Hills, NJ
Signature
/s/ Denis Butkovic, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tasos Konidaris:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Amneal Pharmaceuticals, Inc. Executive Vice President & CFO Class A Common Stock 527K $2.8M $5.31 Mar 12, 2024 Direct
Amneal Pharmaceuticals, Inc. Executive Vice President & CFO Performance-Based Restricted Stock Units 352K $1.92M $5.47 Mar 4, 2024 Direct
Amneal Pharmaceuticals, Inc. Executive Vice President & CFO Restricted Stock Units 0 $0 $5.47 Mar 12, 2024 Direct
Kadmon Holdings, Inc. Director Stock Option (right to buy) 0 $5.54 Nov 9, 2021 Direct

Insider Reports Filed by Tasos Konidaris

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AMRX Amneal Pharmaceuticals, Inc. Mar 12, 2024 3 -$163K 4 Mar 14, 2024 Executive Vice President & CFO
AMRX Amneal Pharmaceuticals, Inc. Mar 1, 2024 11 -$270K 4 Mar 5, 2024 Executive Vice President & CFO
AMRX Amneal Pharmaceuticals, Inc. Mar 12, 2023 2 $0 4 Mar 14, 2023 Executive Vice President & CFO
AMRX Amneal Pharmaceuticals, Inc. Mar 3, 2023 4 $0 4 Mar 7, 2023 Executive Vice President & CFO
AMRX Amneal Pharmaceuticals, Inc. Mar 1, 2023 2 $0 4 Mar 3, 2023 Executive Vice President & CFO
AMRX Amneal Pharmaceuticals, Inc. Mar 12, 2022 2 $0 4 Mar 15, 2022 Executive Vice President & CFO
AMRX Amneal Pharmaceuticals, Inc. Mar 1, 2022 4 $0 4 Mar 3, 2022 Executive Vice President & CFO
KDMN Kadmon Holdings, Inc. Nov 9, 2021 5 -$2.5M 4 Nov 9, 2021 Director
KDMN Kadmon Holdings, Inc. May 12, 2021 1 $0 4 May 13, 2021 Director